Your session is about to expire
← Back to Search
Behavioural Intervention
TENS Active Treatment for Obesity
N/A
Recruiting
Research Sponsored by Elira, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months
Awards & highlights
Study Summary
This trial tests a device combined with lifestyle changes to treat overweight/obese people. It compares the device to a sham device to see if it's safe and effective.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ three months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
A difference in Percent Total Body Weight Loss (%TBWL)
A responder rate of at least 35% in the active treatment
Secondary outcome measures
Changes in BMI
Changes in appetite as measured by Appetite Visual Analogue Scale (VAS)
Changes in eating behaviors as measured by TFEQ scores
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: TENS Active TreatmentExperimental Treatment1 Intervention
Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Management (The Elira System)
Group II: Sham Control DevicePlacebo Group1 Intervention
Sham TENS unit that provides no actual therapy
Find a Location
Who is running the clinical trial?
Elira, Inc.Lead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Sham Control Device
- Group 2: TENS Active Treatment
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger